Cardiotoxic Effects of Chemotherapy in Patients With Sarcomas: A Two and Three-dimensional Echocardiographic Speckle Tracking Imaging Study

Identification of Marker of Primary or Acquired Resistance to Anti Tumorous Treatment

NCT02105168 ·Status: UNKNOWN ·Phase: NA

Liquid Biopsy in Head and Neck Cancer

NCT03926468 ·Status: UNKNOWN

Identification of Prognostic Biomarkers for Progression of Invasive Squamous Cell Carcinoma

NCT02549638 ·Status: TERMINATED

Chart Review of Treatments Received by Patients Diagnosed With Soft Tissue Sarcoma

NCT00322855 ·Status: TERMINATED

Measuring Cell Free DNA During the Course of Treatment for Esophageal Cancer as a Marker of Response and Recurrence

NCT03108885 ·Status: TERMINATED

Quantitative MR Biomarkers for Sarcoma Treatment

NCT01017978 ·Status: COMPLETED ·Phase: NA

Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies

NCT07327489 ·Status: RECRUITING

Biomarkers in Patients With Advanced Rhabdomyosarcoma

NCT01668095 ·Status: COMPLETED

Analysis of Whole Body Magnetic Resonance Imaging and Liquid Biopsy for Early Detection of Cancer in Patients With a Strong Family History of Cancer

NCT05868486 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1

Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs

NCT04985357 ·Status: WITHDRAWN

Liquid Biopsy of Head and Neck Cancer Patients in Blood and Saliva

NCT05122507 ·Status: UNKNOWN

Clinical Application of Liquid Biopsy for Precise Diagnosis and Prognosis in Lymphoma

NCT04062877 ·Status: COMPLETED

Biomarkers in Predicting Response to Rituximab Treatment in Samples From Patients With Indolent Follicular Lymphoma

NCT01381705 ·Status: COMPLETED

Liquid Biopsy in Monitoring the Therapeutic Efficacy of Targeted Therapy in Advanced/Metastatic Gastric Cancer

NCT02610218 ·Status: UNKNOWN

Exploring Cancer-Associated Thromboembolism Prognosis Biomarkers and Polymorphisms

NCT06065592 ·Status: RECRUITING ·Phase: PHASE1

Associations Between Chemotherapy-Induced Nausea in Patients With Genitourinary, Sarcoma or Melanoma Cancers and Changes in Gut Microbiome: Potential for Precision Therapeutics

NCT05819827 ·Status: TERMINATED

Immunophenotyping in Metastatic Kidney Cancer Patients Receiving Ablative Therapy

NCT05112627 ·Status: COMPLETED

ctDNA as a Biomarker for Treatment Response in HNSCC

NCT03540563 ·Status: COMPLETED ·Phase: NA

Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers

NCT00568490 ·Status: RECRUITING

Biomarkers in Predicting Response to Treatment in Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer Treated With Carboplatin, Paclitaxel, and Radiation Therapy

NCT00898430 ·Status: TERMINATED

Correlation Between Tissue and Plasmatic EGFR in CBNPC With EGFR Mutation or Predictive Factor of EGFR Mutation

NCT03265496 ·Status: TERMINATED ·Phase: NA

Metastatic Leiomyosarcoma Biomarker Protocol

NCT05653388 ·Status: RECRUITING

Memory Phenotype and PD-1 Inhibition Response in Oral Cancer

NCT03862066 ·Status: TERMINATED

Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma

NCT00904241 ·Status: ACTIVE_NOT_RECRUITING

Tumor-Informed ctDNA Testing for MRD Following Treatment of Squamous Cell Carcinoma

NCT06606028 ·Status: RECRUITING